Symbiont v. Bjm Feed ( 2022 )


Menu:
  •                       NOTICE: NOT FOR OFFICIAL PUBLICATION.
    UNDER ARIZONA RULE OF THE SUPREME COURT 111(c), THIS DECISION IS NOT PRECEDENTIAL
    AND MAY BE CITED ONLY AS AUTHORIZED BY RULE.
    IN THE
    ARIZONA COURT OF APPEALS
    DIVISION ONE
    SYMBIONT NUTRITION, LLC, et al.,
    Plaintiffs/Appellees,
    v.
    BJM FEED INGREDIENTS, LLC, et al.,
    Defendants/Appellants.
    No. 1 CA-CV 21-0218
    FILED 5-19-2022
    Appeal from the Superior Court in Maricopa County
    No. CV2019-097220
    The Honorable David J. Palmer, Judge
    VACATED AND REMANDED
    COUNSEL
    Bueler Jones, LLP, Chandler
    By Gordon S. Bueler
    Counsel for Plaintiffs/Appellees
    Snell & Wilmer, LLP, Phoenix
    By Cory L. Braddock, Andrew M. Jacobs
    Counsel for Defendants/Appellants
    SYMBIONT, et al. v. BJM FEED, et al.
    Decision of the Court
    MEMORANDUM DECISION
    Judge James B. Morse Jr. delivered the decision of the Court, in which
    Presiding Judge D. Steven Williams and Judge David B. Gass joined.
    M O R S E, Judge:
    ¶1             BJM Feed Ingredients, LLC, John Link, and Matrix Nutrition
    of Texas, LLC (collectively "Defendants") appeal the superior court's entry
    of a preliminary injunction on behalf of Symbiont Nutrition, LLC and Mark
    Holt (collectively "Plaintiffs"). Because the superior court erred, we vacate
    the injunction.
    FACTS AND PROCEDURAL BACKGROUND
    ¶2           In 2016, the United States Patent and Trademark Office issued
    Mark Holt and Matthew Garner a patent for a manufacturing process for
    dairy cow feed. The resulting feed, OZ45, purports to increase cows'
    protein levels and, in turn, improve their reproduction rates and milk
    production. The patented process involves heat-treating and extruding
    corn.
    ¶3           After receiving the patent, Holt transferred his patent rights
    to Symbiont Nutrition, LLC ("Symbiont") to license the patented process.
    Symbiont is an Arizona limited liability company and Holt is its sole
    member. Garner did not assign his patent rights and, at the time of the
    preliminary injunction hearing, still retained his rights in the patent.
    ¶4              In 2017, Holt and John Link formed Matrix Nutrition of Texas,
    LLC ("Matrix"), a Texas limited liability company created to manufacture
    and sell feed using the patented process. Holt and Link each held a 50%
    membership interest in the company. In February 2018, Symbiont and
    Matrix entered a Patent and Know-How License Agreement. The license
    agreement licensed use of the patent to Matrix and provided know-how
    regarding the patented process. The agreement required Matrix to "return
    any and all confidential or trade-secret materials" and "permanently stop
    [its] use of all Licensed Process(es) and all Licensed Product(s)" when the
    agreement ended. Plaintiffs also allege Symbiont and Matrix entered a
    confidentiality and non-disclosure agreement, which required Matrix to
    keep confidential all information related to Symbiont's patent. Plaintiffs,
    2
    SYMBIONT, et al. v. BJM FEED, et al.
    Decision of the Court
    however, failed to produce documentary evidence substantiating this
    allegation, and Defendants contest the existence of such an agreement.
    ¶5            In March 2018, Symbiont entered a similar Patent and Know-
    How License Agreement with BJM Feed Ingredients, LLC ("BJM"), a
    Pennsylvania limited liability company. Link is also a member of BJM
    through Link Feed Ingredients, LLC. The scope of the license granted in
    the BJM agreement is identical to the license granted to Matrix. In
    exchange, BJM agreed to pay Symbiont royalties for feed sold using its
    process. Upon termination, the agreement required BJM to "return any and
    all confidential or trade-secret materials" to Symbiont, "permanently stop"
    its use of the patented process, and hand over "all unpatented data and
    know-how" BJM developed "in the course of [its] efforts to develop
    Licensed Products and Licensed Processes." Further, Symbiont and BJM
    entered a Non-Disclosure and Non-Circumvention Agreement ("NDA").
    The NDA prohibited BJM from disclosing "any proprietary, confidential
    and/or trade secret information of [Symbiont]."
    ¶6             In March 2019, Holt resigned from Matrix and sold his
    membership interest to Link. The same day, Symbiont and Matrix ended
    their license agreement. Days later, Matrix filed termination paperwork
    with the Texas Secretary of State. In May 2019, the Secretary of State filed
    a certificate of termination, dissolving Matrix as an entity.
    ¶7             In June 2019, BJM terminated its license agreement with
    Symbiont. And, in October 2019, BJM began working with Garner to
    manufacture feed. At the end of October, Plaintiffs filed this lawsuit against
    Defendants. Plaintiffs allege four counts: (1) BJM breached its license
    agreement and NDA with Symbiont; (2) Matrix breached its NDA with
    Symbiont; (3) BJM and Matrix converted Plaintiffs' "assets, monies and
    intellectual property"; and (4) Link breached his fiduciary duties of care and
    loyalty to Holt.
    ¶8             Matrix moved to dismiss counts two and three for lack of
    subject matter jurisdiction, arguing both claims arose under patent law
    subject to exclusive federal jurisdiction. The superior court denied Matrix's
    motion, stating it "agree[d] with Plaintiff's position" that "the resolution of
    the case is not dependent on the application of patent law or a
    determination that a patent has been infringed, and/or that patent law does
    not 'in any sense' create the breach of contract or conversion claims at issue
    here[.]"
    3
    SYMBIONT, et al. v. BJM FEED, et al.
    Decision of the Court
    ¶9           Subsequently, Plaintiffs moved for a preliminary injunction
    against Defendants. Specifically, Plaintiffs asked the court to enjoin
    Defendants from "the continued use of Plaintiffs' patents" and "transferring
    or otherwise distributing Plaintiffs' patent and proprietary information,
    technology and know-how." After several delays, the court held an
    evidentiary hearing on Plaintiffs' motion in October 2020. At the conclusion
    of the hearing, the court requested the parties submit written closing
    arguments.
    ¶10            The court granted Plaintiffs' motion and enjoined Defendants
    from (1) "manufacturing or selling OZ45 using Plaintiff[s'] patented process
    and know-how"; (2) "discussing Plaintiff[s'] patented process and know-
    how with other persons or entities"; and (3) "soliciting others to use
    Plaintiff[s'] processes, information, know how, technology and any
    improvements." The court also ordered the Defendants to "return all
    confidential and trade and secret information" they received under both the
    BJM and Matrix licensing agreements.
    ¶11           Defendants timely appealed. We have jurisdiction under
    A.R.S. § 12-2101(A)(5)(b).
    DISCUSSION
    I.     Subject-Matter Jurisdiction.
    ¶12           As a threshold issue, we must address Defendants' argument
    that federal patent law preempts Plaintiffs' claims because the claims hinge
    on whether Defendants' conduct infringed Plaintiffs' patent. We review the
    superior court's jurisdiction de novo, Medina v. Ariz. Dep't. of Transp., 
    185 Ariz. 414
    , 417 (App. 1995), and conclude state courts may hear state-law
    claims that implicate "run-of-the-mill question[s] of infringement," Inspired
    Dev. Grp., LLC v. Inspired Prods. Grp., LLC, 
    938 F.3d 1355
    , 1369 (Fed. Cir.
    2019).
    ¶13             Federal courts have exclusive jurisdiction, effectively
    preempting state-court jurisdiction, over any case "arising under any Act of
    Congress relating to patents." 
    28 U.S.C. § 1338
    (a). A case can "arise under"
    federal patent law in two ways. Gunn v. Minton, 
    568 U.S. 251
    , 257 (2013).
    First, a case arises under federal patent law when federal patent law creates
    the cause of action. 
    Id.
     Second, in instances "where a claim finds its origins
    in state rather than federal law," the Supreme Court has "identified a
    'special and small category' of cases in which arising under jurisdiction still
    lies." 
    Id. at 258
     (citation omitted). Gunn clarified that exclusive "federal
    jurisdiction over a state law claim will lie if a federal issue is: (1) necessarily
    4
    SYMBIONT, et al. v. BJM FEED, et al.
    Decision of the Court
    raised, (2) actually disputed, (3) substantial, and (4) capable of resolution in
    federal court without disrupting the federal-state balance approved by
    Congress." 
    Id.
     A plaintiff's claim must satisfy all four prongs of the test for
    exclusive federal jurisdiction to lie. 
    Id.
    ¶14            Because exclusive federal jurisdiction is an issue of federal
    law, we look to the decisions of the federal courts "as persuasive authority."
    Arizonans for Second Chances, Rehab., & Pub. Safety v. Hobbs, 
    249 Ariz. 396
    ,
    412, ¶ 60 n.6 (2020).1 Recently, in Blackhawk Network Inc. v. SL Card Co. Inc.,
    the United States District Court for the District of Arizona dismissed a state-
    law breach of contract claim for lack of subject-matter jurisdiction even
    though the claim depended on adjudicating issues of patent infringement.
    --- F. Supp. 3d ---, ---, 
    2022 WL 704032
    , at *9-11 (D. Ariz. Mar. 9, 2022).2 We
    proceed using Blackhawk as a guide.
    ¶15             All four of Plaintiffs' claims originate in state law but
    exclusive federal jurisdiction may still lie if those claims fall under the
    "special and small category" of state-law claims that raise substantial
    questions under federal patent law. Although the parties debate whether
    Plaintiffs' claims necessarily raise a disputed patent issue, we need not
    resolve this disagreement:
    Even assuming the claims necessarily raise a federal patent
    law issue, and the issue is actually disputed, . . . the issue is
    not "substantial" in the relevant sense. The substantiality
    inquiry is focused not "on the importance of the issue to the
    plaintiff's case and to the parties before it," but rather on "the
    importance of the issue to the federal system as a whole."
    1      Other state's courts have reached contradictory decisions on this
    point. Compare Point Conversions, LLC v. WPB Hotel Partners, LLC, 
    324 So. 3d 947
     (Fla. Dist. Ct. App. 2021) (determining that state-law claims that
    turned on issues of patent infringement were not preempted ), review
    granted, SC21-1071, 
    2021 WL 5804319
     (Fla. Dec. 7, 2021), with Point
    Conversions, LLC v. Omkar Hotels, Inc., 
    321 So. 3d 326
     (Fla. Dist. Ct. App.
    2021) (deciding that essentially identical state-law claims were subject to
    exclusive federal jurisdiction).
    2      The district court recently amended its decision but did not change
    its federal jurisdiction analysis. See Blackhawk Network Inc. v. SL Card Co.
    Inc., CV-21-00813-PHX-MTL, 
    2022 WL 1136633
    , at *1-2 (D. Ariz. Apr. 18,
    2022).
    5
    SYMBIONT, et al. v. BJM FEED, et al.
    Decision of the Court
    
    Id.
     at ---, *9 (quoting Gunn, 
    568 U.S. at 260
    ).
    ¶16           As in Blackhawk, "[t]he patent law issues implicated in this
    case carry no such significance." 
    Id.
     at ---, *9; see also Inspired Dev., 938 F.3d
    at 1364 (stating the "touchstone" for substantiality is whether state-court
    involvement would undermine uniform patent law). Federal courts have
    developed a three-factor test to guide the substantiality inquiry:
    A substantial federal issue is more likely to be present if:
    a) a pure issue of federal law is dispositive of the case,
    b) the court's resolution of the issue will control numerous
    other cases, [and]
    c) the Government has a direct interest in the availability of a
    federal forum to vindicate its own administrative action.
    Inspired Dev., 938 F.3d at 1364 (cleaned up and citation omitted).
    ¶17            All three factors weigh against considering Plaintiffs' claims
    as raising a substantial federal patent issue. First, Plaintiffs' claims
    "involve[] a question of federal law, at most, as only one of several elements
    needed to prevail." NeuroRepair, Inc. v. The Nath Law Grp., 
    781 F.3d 1340
    ,
    1346 (Fed. Cir. 2015). While issues of federal patent law may be embedded
    in Plaintiffs' claims, the resolution of their claims rests ultimately on the
    application of Arizona law, not federal patent law. To succeed on counts
    one and two, Plaintiffs must prove the existence and validity of the
    licensing and nondisclosure agreements, that these agreements governed
    Defendants' conduct, and that Defendants' conduct violated the
    agreements. Similarly, Plaintiffs' conversion claim turns on a showing of
    Plaintiffs' ownership or right to possession of certain property and
    Defendants' wrongful interference with that property. Autoville, Inc. v.
    Friedman, 
    20 Ariz. App. 89
    , 91-92 (1973). Finally, Plaintiffs' fiduciary duty
    claim rests on Plaintiffs proving the existence of such a duty and
    Defendants' breach of that duty. Arizona law, not federal patent law, is
    dispositive of each of these claims. See Blackhawk, --- F. Supp. 3d at ---, 
    2022 WL 704032
    , at *10-11 (finding an issue of federal patent law was not
    dispositive when a breach of contract claim required the court to determine
    whether one set of patents infringed on another set of patents).
    Accordingly, the first factor cuts against treating the patent issue as
    substantial.
    6
    SYMBIONT, et al. v. BJM FEED, et al.
    Decision of the Court
    ¶18            Second, because the state court's resolution of any embedded
    patent issues in this case "will have no real-world impact on the validity,
    scope, or ownership of the parties' patent[ ]," any patent issues amount to a
    "hypothetical 'case within a case.'" 
    Id.
     at ---, *11; see also NeuroRepair, 781
    F.3d at 1347 ("If the state court action would neither affect the scope of any
    live patent nor require resolution of a novel issue of patent law, it is unclear
    how it could control numerous other cases or impact the federal system as
    a whole."). Although the adjudication of Plaintiffs' claims may require the
    court to determine whether Defendants used a feed-manufacturing process
    that infringed on Plaintiffs' patented process, there is little to suggest that
    the state court's analysis of this issue "will affect uniformity in patent law."
    Inspired Dev., 938 F.3d at 1366; see also Gunn, 
    568 U.S. at 262
     ("[F]ederal
    courts are of course not bound by state court case-within-a-case patent
    rulings."). Indeed, the embedded patent issues in this case are "fact-bound
    and situation-specific" and will have no precedential effect on federal courts
    or federal patent law generally. See Gunn, 
    568 U.S. at 263
     (stating that even
    if "a state court's case-within-a-case adjudication may be preclusive under
    some circumstances," the resulting "'fact-bound and situation-specific'
    effects are not sufficient to establish federal arising under jurisdiction"
    (quoting Empire Healthchoice Assurance, Inc. v. McVeigh, 
    547 U.S. 677
    , 701
    (2006))). Nor do Plaintiffs' claims raise novel patent issues. To the extent
    they raise patent issues, they are ones of basic infringement. See Inspired
    Dev., 938 F.3d at 1366-67 (noting Gunn "suggests that state courts can
    faithfully apply federal precedent to embedded issues of basic infringement
    and invalidity in a particular case"). Thus, the second factor also militates
    against substantiality.
    ¶19            Third, "[g]iven the 'fact-bound' nature of the embedded
    patent law issues" in this case, the government has no direct interest
    litigating this suit in a federal forum. Id. at 1368-69 (quoting MDS (Can.)
    Inc. v. Rad Source Techs., Inc., 
    720 F.3d 833
    , 842 (11th Cir. 2013)). Plaintiffs'
    claims implicate only one potential patent issue: whether Defendants' feed
    manufacturing process infringed Plaintiffs' patent in violation of the
    parties' agreements. See Blackhawk, --- F. Supp. 3d at ---, 
    2022 WL 704032
    , at
    *11 (finding no direct government interest where the dispute "involve[d]
    comparing the claims of four particular patents to determine whether this
    particular invention was impermissibly used by these particular
    Defendants"). Because the "government interest in having any single case
    of patent infringement heard in a federal forum is limited," the final factor
    additionally counsels against substantiality. Inspired Dev., 938 F.3d at 1369
    (quoting MDS, 720 F.3d at 842).
    7
    SYMBIONT, et al. v. BJM FEED, et al.
    Decision of the Court
    ¶20            Defendants rely extensively on Jang v. Boston Scientific
    Corporation, 
    767 F.3d 1334
     (Fed. Cir. 2014) to argue the patent issues are
    substantial because Plaintiffs' claims are "neither entirely backward-
    looking nor hypothetical." Defendants' reliance on Jang is misplaced. Jang
    addressed whether a claim filed in federal court on diversity of citizenship
    grounds should be appealed to the Federal Circuit or a regional circuit. Id.
    at 1338. This issue is materially different from determining whether a state-
    law claim touching on issues of patent infringement should be heard in
    state or federal court. As Inspired Development explains, "the reasoning in
    Jang turned on the system-wide conflict that could arise in the federal courts
    if regional circuits reached different conclusions about validity." 938 F.3d
    at 1365. Thus, "[g]iven the 'serious uncertainty' of whether a district court
    would follow its regional circuit or the federal circuit, such conflicts raised
    'substantial' concerns for the federal system[,]" and the patent issues were
    substantial enough to confer jurisdiction on the Federal Circuit. Id. (citation
    omitted). Even if the patent issues here are not entirely backward-looking
    or hypothetical, the risk of creating a system-wide conflict in the federal
    courts is absent. Accordingly, unlike in Jang, in this case, Plaintiffs' claims
    do not raise substantial federal patent issues. See Gunn, 
    568 U.S. at 262
     ("If
    the question arises frequently, it will soon be resolved within the federal
    system, laying to rest any contrary state court precedent; if it does not arise
    frequently, it is unlikely to implicate substantial federal interests.").
    ¶21           In sum, even though the issue of patent infringement might
    be "vitally important" to deciding Plaintiffs' four state-law claims,
    "something more, demonstrating that the [patent] question is significant to
    the federal system as a whole, is needed" to establish exclusive federal
    jurisdiction. Gunn, 
    568 U.S. at 263-64
    . That "something more" is missing
    here. Accordingly, the superior court correctly denied Defendants' motions
    to dismiss.
    II.    Preliminary Injunction.
    ¶22           We turn now to whether the superior court properly enjoined
    Defendants. We review the superior court's grant of a preliminary
    injunction for an abuse of discretion. Shoen v. Shoen, 
    167 Ariz. 58
    , 62 (App.
    1990). "An abuse of discretion exists if the superior court applied the
    incorrect substantive law or preliminary injunction standard, based its
    decision on an erroneous material finding of fact, or applied the appropriate
    preliminary injunction standard in a manner resulting in an abuse of
    discretion." TP Racing, L.L.L.P. v. Simms, 
    232 Ariz. 489
    , 492, ¶ 8 (App. 2013).
    8
    SYMBIONT, et al. v. BJM FEED, et al.
    Decision of the Court
    ¶23            A party seeking a preliminary injunction must establish: "(1)
    a strong likelihood of success on the merits, (2) the possibility of irreparable
    harm if the relief is not granted, (3) the balance of hardship favors the party
    seeking injunctive relief, and (4) public policy favors granting the injunctive
    relief." Fann v. State, 
    251 Ariz. 425
    , 432, ¶ 16 (2021). The crucial factor is
    relative hardship, which requires the movant to show either "1) probable
    success on the merits and the possibility of irreparable injury; or 2) the
    presence of serious questions and the balance of hardships tips sharply in
    the [movant's] favor." Schoen, 
    167 Ariz. at 63
     (citation and internal quotation
    marks omitted). "The greater and less reparable the harm, the less the
    showing of a strong likelihood of success on the merits need be.
    Conversely, if the likelihood of success on the merits is weak, the showing
    of irreparable harm must be stronger." Fann, 251 Ariz. at 432, ¶ 16 (quoting
    Smith v. Ariz. Citizens Clean Elections Comm'n, 
    212 Ariz. 407
    , 410 ¶ 10 (2006)).
    ¶24            The superior court erred when it relied on Smith International
    Inc. v. Hughes Tool Co., 
    718 F.2d 1573
     (Fed. Cir. 1983) to conclude "immediate
    irreparable harm is presumed" in patent-infringement cases. In eBay Inc. v.
    MercExchange, LLC, the Supreme Court rejected any presumption of
    irreparable harm and held that "traditional principles of equity" govern the
    decision whether to grant or deny injunctive relief in patent infringement
    cases. 
    547 U.S. 388
    , 391, 394 (2006); see also Robert Bosch LLC v. Pylon Mfg.
    Corp., 
    659 F.3d 1142
    , 1149 (Fed. Cir. 2011) (noting "eBay abolishes our
    general rule that an injunction normally will issue when a patent is found
    to have been valid and infringed"). More importantly, although Plaintiffs'
    claims raise issues of patent infringement, they do not assert a patent-
    infringement claim. Instead, because Plaintiffs bring only state-law claims,
    the superior court must apply Arizona law, which does not presume
    irreparable harm, to determine whether to issue injunctive relief. See Fann,
    251 Ariz. at 432, ¶ 16 (requiring a showing of the possibility of irreparable
    harm to grant a preliminary injunction).
    ¶25             Here, Plaintiffs were required to show the possibility of
    irreparable harm "not remediable by damages." Shoen, 
    167 Ariz. at 63
    . An
    award of monetary damages generally is an adequate remedy when
    damages are calculable with reasonable certainty and "address the full
    harm suffered." IB Prop. Holdings, LLC v. Rancho Del Mar Apartments Ltd.
    P'ship, 
    228 Ariz. 61
    , 65, ¶¶ 10-11 (App. 2011). Because the court presumed
    irreparable harm, it never determined whether Plaintiffs met their burden.
    See id. at ¶ 10 ("[T]he party seeking an injunction must show a possibility of
    irreparable injury 'not remediable by damages'" (quoting Shoen, 
    167 Ariz. at 63
    )). Accordingly, the superior court abused its discretion in enjoining
    defendants.
    9
    SYMBIONT, et al. v. BJM FEED, et al.
    Decision of the Court
    CONCLUSION
    ¶26          We vacate the superior court's preliminary injunction and
    remand for further proceedings consistent with this decision.
    AMY M. WOOD • Clerk of the Court
    FILED: AA
    10